On 12/5/2021, in Hanoi, Professor, Dr. Tran Van Thuan, Deputy Minister of Health received 10,000 SARS-CoV-2 test kits for epidemic prevention by Pharmaceutical Joint Stock Company. awarded by Ampharco USA.
Speaking at the Reception Ceremony, Professor, Dr. Tran Van Thuan, Deputy Minister of Health welcomed Ampharco USA Pharmaceutical Joint Stock Company to use technology transferred from Military Medical Academy to research and produce. test kit “made in Vietnam”.
Deputy Minister of Health emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of social and economic life, the Ampharco USA accompanying the Health sector to support 10,000 test kits is a job. It is very meaningful, demonstrating the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19 ”. The AmphaBio HT- Hithroughput PCR COVID-19 kit can detect most of the strains of the SARS-CoV-2 virus to date. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. Professor, Dr. Do Quyet, Director of Military Medical Academy, said that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of USA. Military Medical Academy always creates the most optimal conditions for the academy’s scientists to research and develop highly and timely applied products in COVID-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health has established a Committee to advocate and coordinate the COVID-19 epidemic prevention and control support. The Ministry of Health agreed to receive 10,000 test kits for SARS-CoV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company.
However, in order to ensure the storage conditions of the 10,000 test tests mentioned above, the Ministry of Health requested the Company to assist in storing and preserving the above-mentioned kits that supported the prevention of the above epidemic at the preservation warehouse of the Company. ty. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test kits to medical facilities to serve the COVID-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company supports to transport and hand over the testing kit to units and localities promptly according to regulations.
You must log in to post a comment.